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Abstract
IL-10 is an anti-inflammatory cytokine that regulates the extent of host immunity to infection by exerting suppressive effects
on different cell types. Herpes viruses induce IL-10 to modulate the virus-host balance towards their own benefit, resulting
in prolonged virus persistence. To define the cellular and molecular players involved in IL-10 modulation of herpes virus-
specific immunity, we studied mouse cytomegalovirus (MCMV) infection. Here we demonstrate that IL-10 specifically curtails
the MCMV-specific CD4 T cell response by suppressing the bidirectional crosstalk between NK cells and myeloid dendritic
cells (DCs). In absence of IL-10, NK cells licensed DCs to effectively prime MCMV-specific CD4 T cells and we defined the pro-
inflammatory cytokines IL-12, IFN-c and TNF-a as well as NK cell activating receptors NKG2D and NCR-1 to regulate this
bidirectional NK/DC interplay. Consequently, markedly enhanced priming of MCMV-specific CD4 T cells in Il102/2 mice led
to faster control of lytic viral replication, but this came at the expense of TNF-a mediated immunopathology. Taken
together, our data show that early induction of IL-10 during MCMV infection critically regulates the strength of the innate-
adaptive immune cell crosstalk, thereby impacting beneficially on the ensuing virus-host balance for both the virus and the
host.
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Introduction
Persistent viral infections are very widespread in mammalian
hosts and are often associated with relevant clinical symptoms
which can culminate in fatal disease [1]. The establishment of a
persistent viral infection requires specific viral properties to
achieve co-existence with potent antiviral defense mechanisms.
Viruses have therefore evolved various strategies to effectively
modulate or hide from host immunity. Herpes viruses, including
cytomegalovirus (CMV), encode for immune evasion proteins,
which either affect antigen presentation, innate immune signaling
or modulate host cytokine responses [2]. IL-10 is an anti-
inflammatory cytokine that plays an important role in the
regulation of host immunity to infection [3]. It acts by multiple
immunosuppressive modes, mainly affecting the expression of pro-
inflammatory cytokines and chemokines, modulating the function
of antigen-presenting cells and directly or indirectly suppressing
effector T cell responses [4]. IL-10 is expressed during a number of
persistent viral infections and might on the one hand favor viral
replication and persistence by suppressing antiviral defense
mechanisms, but on the other hand might also be beneficial for
the host by limiting immunopathology in the setting of antigen
persistence and active antiviral immunity. Herpes viruses such as
CMV and EBV exploit the functions of cellular IL-10 by encoding
for viral IL-10 homologues [5] and by interfering with the IL-10R
signaling pathway. Consistent with an immunosuppressive role of
the viral IL-10 homologue, a recent study in rhesus macaques
infected with a CMV lacking the RhCMV homologue of IL-10
(rhcmv-IL-10) reported enhanced T and B cell immunity [6].
Mouse CMV does not encode for its own IL-10 homologue but
instead uses cellular IL-10 to modulate host immunity. Thus,
endogenous IL-10 promotes virus replication in the salivary gland,
an important mucosal site of virus persistence, which is likely to
facilitate horizontal transmission of the virus [7]. A role of IL-10
for promoting virus persistence has also been show in chronic
LCMV Clone 13 infection, where the absence of IL-10 led to virus
clearance and restored functionality of LCMV-specific CD8 T
cells [8,9]. Conversely with IL-10 being an important regulator of
host immunity, it is implied to attenuate host tissue damage that
could occur during unregulated antiviral immunity, in particular
PLoS Pathogens | www.plospathogens.org 1 August 2012 | Volume 8 | Issue 8 | e1002846
in the context of chronic infection. Indeed, MCMV-infected
Il102/2 mice were reported to exhibit increased liver pathology
and severity of MCMV disease, which was ameliorated by
administration of recombinant IL-10 [10].
The impact of IL-10 during the early phase of persistent viral
infections, in particular for the induction of adaptive immunity,
has not yet been extensively evaluated. Here we investigate in vivo
the role of cellular IL-10 during acute MCMV infection with
specific emphasis on its regulation of innate-adaptive crosstalk. We
show that IL-10 specifically limits MCMV-specific CD4 T cell
responses, but not CD8 T cell responses, by suppressing myeloid
CD8a2 DC and NK cell function. Via interfering with the NK/
DC crosstalk, IL-10 suppressed the induction of CD4 T cell
protective immunity, facilitated MCMV persistence, but prevent-
ed development of TNF-a mediated immunopathology. Taken
together, our data establish that induction of IL-10 during acute
CMV infection plays an important role in regulating the
magnitude of innate-adaptive crosstalk, thus altering the balance
between the virus and the host.
Results
Il102/2 mice show increased body weight loss and
reduced viral loads during acute MCMV infection
Early control of MCMV replication in C57BL/6 mice is to a
large extent mediated by NK cells, due to their robust activation
via interaction of Ly49H activating receptor on NK cells and
MCMV protein m157 expressed on the surface of infected cells
[11]. However, it was shown that the majority of wild type (wt)
strains of MCMV does not encode for the m157 sequence that
trigger NK cell responses through the engagement of the Ly49H
receptor, indicating that the strong NK cell response mediated via
Ly49H early upon MCMV infection is unlikely to be a very
representative situation [12]. We therefore used an m157 deletion
mutant virus to avoid massive activation of NK cells via Ly49H.
However, we corroborated our main findings with m157-sufficient
wt MCMV (Fig. S8, S9).
Based on recently published data that induction of IL-10 during
MCMV infection promotes virus persistence in the salivary glands
and decreases latent viral loads [7,13], we were interested to define
the time point when IL-10 starts to influence the MCMV control
in various organs. We found that MCMV-infected Il102/2 mice
exhibited reduced virus loads already during acute infection
(Figure 1A). While virus titers in the salivary gland and lungs were
comparable with B6 mice at day 7 post infection (p.i.), they were
considerably diminished at day 14 and 21 p.i. in Il102/2 mice.
Elevated levels of pro-inflammatory cytokines IFN-c and TNF-a
were found at day 5.5 of infection in Il102/2 mice (Figure 1B).
Furthermore, Il102/2 mice developed enhanced body weight loss
early upon infection (Figure 1C), reaching the nadir between day 5
and 6 p.i., but recovered thereafter to B6 weight levels by day
14 p.i. To determine whether the increased body weight loss in
Il102/2 mice was a consequence of excessive cytokine production,
we neutralized TNF-a (Figure 1C), since neutralization of IFN-c
was reported to have no effect on the development of pathology in
Il102/2 mice [14]. Notably, neutralization of TNF-a abolished
body weight loss in Il102/2 mice, indicating that unregulated
secretion of TNF-a mediated the development of pathology in
Il102/2 mice (Figure 1C).
To address whether the enhanced control of viral replication in
Il102/2 mice was caused by T cells, we used aCD4 and aCD8
depleting antibodies to eliminate the respective cell types
(Figure 1D). We found that Il102/2 mice depleted of CD4 T
cells exhibited significantly increased virus titers compared to PBS
treated Il102/2 mice, indicating a pivotal role of CD4 T cells in
the enhanced MCMV control in Il102/2 mice. In contrast, CD8
T cells were dispensable for increased anti-MCMV immunity in
Il102/2 mice, since their depletion did not affect virus control.
Moreover, CD4 T cell depleted Il102/2 mice showed reduced
body weight loss compared to untreated Il102/2 mice (Figure 1E).
Thus, we conclude that CD4 T cells are responsible for the
enhanced MCMV control and contribute to body weight loss
observed in Il102/2 mice. However, other cell types likely
contribute to increased body weight loss in Il102/2 mice as well,
since CD4 T cell depleted Il102/2 mice still lost more body weight
than untreated B6 mice (Figure 1E).
Taken together, these data demonstrate that Il102/2 mice
harbor reduced viral loads at the expense of increased body weight
loss during the acute phase of MCMV infection due to the action
of CD4 but not CD8 T cells. Hence, IL-10 has a dual role during
the course of early MCMV infection; it inhibits the development of
pathology, which is beneficial for the host, but at the same time it
promotes lytic replication of the virus for prolonged time periods,
which is beneficial for transmission of the virus.
IL-10 differentially affects MCMV-specific CD4 vs CD8 T
cell responses during acute infection
To investigate in more detail the CD4 dependent regulation of
virus control in Il102/2 mice, we analyzed the pool size and
functionality of virus-specific CD4 and CD8 T cells upon MCMV
infection. T cells were isolated from different organs and ex vivo
restimulated with MCMV-derived CD4 and CD8 T cell peptide
epitopes (Figure 2). We found that Il102/2 mice showed markedly
increased frequencies and total numbers of MCMV-specific CD4
T cells producing IFN-c and TNF-a at day 14 p.i. This massive
Author Summary
Cytomegalovirus (CMV) infections are very widespread in
mammalian hosts. Despite the fact that CMVs are usually
well controlled by the immune system, they cause
persistent life-long infection and have evolved a number
of strategies to effectively modulate or hide from host
immunity. Since the establishment of an immunosuppres-
sive environment favors virus persistence, IL-10 is one of
the host targets that CMVs actively use to tune the virus-
host balance toward their own benefit, resulting in
prolonged virus persistence and hence increased chance
for horizontal transmission. Here, we delineate the
mechanisms of how IL-10 exerts its powerful immune-
suppressing function in the context of murine cytomeg-
alovirus (MCMV) infection. We found that IL-10 specifically
restrains the priming of MCMV-specific CD4 T cell
responses by suppressing dendritic cell (DC) - natural killer
cell (NK) crosstalk during acute MCMV infection. Target
molecules mediating this bi-directional crosstalk between
DCs and NK cells were the pro-inflammatory cytokines IL-
12, IFN-c and TNF-a as well as NK cell activating receptors
NKG2D and NCR-1 and all of them were markedly
suppressed by IL-10. A consequence resulting from this
impeded DC-NK cross-talk by IL-10, leading to poor
priming of MCMV-specific CD4 T cell responses was
increased lytic CMV persistence and reduced development
of host tissue damage. Our study indicates that early
induction of IL-10 during MCMV infection critically regu-
lates the strength of the innate-adaptive crosstalk, thereby
imparting on the ensuing virus-host balance for the
benefit of both the virus and the host.
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Figure 1. Il102/2 mice show reduced virus loads and increased body weight loss during acute MCMV infection. B6 and Il102/2 mice
were infected i.v. with 56106 PFU Dm157 MCMV. A) Virus titers on different days post infection were determined in lungs and salivary glands. Each
symbol represents one individual mouse, horizontal line indicates the mean (n = 3–6, dashed line indicates detection limit). Data are representative of
3 independent experiments. B) IFN-c, TNF-a and IL-12 protein concentrations were determined in the sera of B6 and Il102/2 mice at day 5.5 post
infection by cytometric bead array (BD, Bioscience) and murine IL-12 ELISA Kit (Peprotech). Each symbol represents one individual mouse, horizontal
line indicates the mean (n = 3). Data are representative of 2 independent experiments. C, E) Body weight change of B6 and Il102/2 mice was
measured up to 14 or 20 days post infection. Change in percentage of body weight relative to day 0 is shown. One group of Il102/2 mice was treated
with a neutralizing anti-TNF-a antibody (C) or depleted of CD4 T cells (E). Right panel in E indicates the same experiment showing significances for
day 6 p.i. Data are representative of 3 independent experiments. Each symbol represents the mean of 3 mice per group, error bars indicate the
standard deviation. D) Virus titers in lungs and salivary glands on day 14 post infection of B6 and Il102/2 mice with or without depletion of CD4 or
CD8 T cells. Each symbol represents one individual mouse, horizontal line indicates the mean (n = 5–7, dashed line indicates detection limit). Pooled
data from 2 independent experiments are shown. Statistical analysis was performed by 2-tailed unpaired student’s t-test (* p,0.05, ** p,0.01,
*** p,0.001).
doi:10.1371/journal.ppat.1002846.g001
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increase of MCMV-specific CD4 T cells was apparent in all
organs tested (Figure 2A, B).
In contrast, MCMV-specific CD8 T cell responses were not
significantly affected in Il102/2 mice during acute infection.
MCMV infection shapes the CD8 T cell response in a particular
way, concomitantly driving the accumulation of CD8 T cells
specific for certain viral peptides (inflationary responses) and
inducing classical expansion/contraction kinetics of others (con-
ventional responses). We analyzed the size of one representative
CD8 T cell response of the conventional and inflationary type of
MCMV-specific CD8 T cells [15]. We found that conventional
(specific for the M45 epitope) as well as inflationary (specific for the
M38 epitope) CD8 T cell responses were comparable in MCMV-
infected Il102/2 and B6 mice (Figure 2C, Figure S1). Taken
together, these data establish that IL-10 differentially affects T cell
populations during the acute phase of infection; while it
profoundly inhibits virus-specific CD4 T cell response it has only
a minor impact on MCMV-specific CD8 T cell responses.
Early induction of IL-10 suppresses CD8a2CD11b+ DC
maturation and leads to poor CD4 T cell priming during
MCMV infection
Since we observed a major impact of IL-10 on the virus-specific
CD4 T cell response, we were interested to identify whether IL-10
is acting directly on CD4 T cells or indirectly through the
modulation of the quality and phenotype of APCs. We addressed
the first possibility by generating mixed bone marrow (BM)
chimeras in which only CD4 T cells were either deficient or
sufficient for the IL-10Rb or in which all cells lacked IL-10Rb
expression. While the latter group exhibited massively increased
numbers MCMV-specific CD4 T cells upon infection and showed
increased control of viral replication, CD4 T cell responses in the
presence or absence of IL-10Rb selectively on CD4 T cells
resulted in similarly low frequencies of MCMV-specific CD4 T
cells as in presence of IL-10Rb on CD4 T cells, indicating that
direct IL-10 signaling on CD4 T cells does not constrain the size of
Figure 2. IL-10 differentially affects MCMV-specific CD4 vs CD8 T cell responses. B6 or Il102/2 mice were infected i.v. with 56106 PFU
Dm157 MCMV. Lymphocytes from spleen, lungs, liver and salivary gland (A) or lung (B) were isolated at day 14 post infection and ex vivo restimulated
with appropriate peptides. A, B) CD4 T cells were restimulated with a pool of M14, m18, M25, M112, m139 and m142 peptides (CD4 peptide pool, A,
B), or with M25 and m142 peptide alone (B). Fold increase in percentage of IFN-c+ TNF-a+ peptide-specific CD4 T cells between Il102/2 and B6 mice
(A, right panel, (n = 3), data are representative for at least 3 experiments, error bars indicate the standard deviation). (B) Total numbers (lower row)
and percentages (upper row) of IFN-c + TNF-a+ peptide-specific CD4 T cells from B6 and Il102/2 mice. C) Lung lymphocytes were isolated from
infected mice and M45- or M38-specific CD8 T cells were quantified by tetramer staining (n = 3, data are representative from at least 3 experiments,
error bars indicate the standard deviation). Statistical analysis was performed by 2-tailed unpaired student’s t-test (* p,0.05, ** p,0.01, *** p,0.001).
doi:10.1371/journal.ppat.1002846.g002
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the MCMV-specific CD4 T cell pool (Figure S2 and Text S1).
However, viral titers in the salivary gland were to some extent
reduced by selective absence of IL-10Rb on CD4 T cells,
suggesting a role for IL-10R signaling in CD4 T cells in this
particular tissue (Figure S2).
Next, we sought to investigate whether the absence of IL-10
modulates the phenotype and function of APCs and thereby
enhances the priming of virus-specific CD4 T cells. The absence of
IL-10 led to an increase of the CD11b+CD11c+MHCII+B2202
myeloid DC population, which was most pronounced at day
5.5 p.i. (Figure 3A). In contrast, the lack of IL-10 had no effect on
the CD8a+CD11c+MHCII+B2202 DC compartment, which was
reduced in numbers compared to naive control mice, but to the
same extent in B6 and Il102/2 mice. Consistent with this early
expansion of myeloid DCs, we observed a greatly increased virus-
specific CD4 T cell response already at day 5.5 p.i. (Figure 3C). In
contrast, corroborating our results from day 14 p.i. (Figure 2C),
virus-specific CD8 T cell responses were not affected by the lack of
IL-10 at day 5.5 p.i. (Figure 3C). Since the CD8a+ DC subset is
instrumental for priming of MCMV-specific CD8 T cells [16], the
fact that IL-10 does not influence this DC population could
explain why absence of IL-10 does not impact on MCMV-specific
CD8 T cell responses (Figure 3A).
Next, we analyzed the expression levels of MHCII and
costimulatory molecules on the surface of myeloid DCs
(Figure 3B). We observed a downregulation of MHCII expression
on CD8a2CD11b+CD11c+ DCs in infected mice compared to
naive controls, which was the similar for B6 and Il102/2 mice. In
Figure 3. IL-10 alters the phenotype and function of DCs. B6 and Il102/2 mice were infected with 56106 PFU Dm157 MCMV. A) Splenocytes
from infected mice were isolated at day 5.5 p.i. Representative FACS plots showing CD11c and I-A/I-E stainings of total spleen leukocytes (upper row).
Total numbers of CD11c+CD8a2CD11b+MHCII+B2202 DCs and CD11c+CD8a+MHCII+B2202 DCs from infected B6 and Il102/2 mice and naive Il102/2
mice are shown (lower row, n= 3 except for naive Il102/2 mice n= 1; data are representative for at least 3 experiments, error bars indicate the
standard deviation). B) Expression levels of I-A/I-E and costimulatory molecules CD80, CD86 and CD40. Plots are gated on CD11c+CD8a2MH-
CII+B2202DC population at day 5.5 p.i. are shown (n= 3, error bars indicates standard deviation, data are representative from at least 3 experiments).
Representative FACS pots (left column) and summary of MFI data (right column). C) Lung lymphocytes were isolated at day 5.5. p.i. and CD4 T cells
were restimulated with a pool of M14, m18, M25, M112, m139 and m142 peptides (CD4 peptide pool) and CD8 T cells were restimulated with M45
peptide. Total numbers of IFN-c+ TNF-a+ peptide specific CD4 and CD8 T cells are shown (n= 3, error bars indicate standard deviation, data are
representative from at least 3 experiments). D) Splenic CD11c+ cells isolated at day 3.5 p.i. from B6 and Il102/2 mice were enriched by MACS, loaded
with M25 peptide and incubated with the naive MACS purified CFSE labeled TCR transgenic CD4 T cells specific for the M25 protein (M25-II cells) for 3
days. The frequencies of CFSElow M25 II cells are indicated in the representative FACS plot. (n = 3 triplicates of respective cell cultures, data are
representative of 3 independent experiments). Statistical analysis was performed by 2-tailed unpaired student’s t-test (* p,0.05, ** p,0.01,
*** p,0.001).
doi:10.1371/journal.ppat.1002846.g003
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contrast, expression levels of CD80, CD86 and CD40 costimu-
latory molecules on CD8a2CD11b+CD11c+ DCs were consis-
tently higher in Il102/2 mice compared to their B6 counterparts.
These effects were most pronounced at day 5.5 p.i. but some of the
differences were already apparent at day 3.5 p.i. (data not shown).
Of note, expression levels of costimulatory molecules on
CD8a+CD11c+ DCs were comparable in B6 and Il102/2 mice,
further supporting our observation that CD8 T cell responses are
not affected by the presence or absence of IL-10 (Figure S3).
Finally, to assess the functional consequences of these phenotypic
differences in myeloid DCs of Il102/2 mice, we directly analyzed
the capacity of DCs isolated from MCMV-infected B6 or Il102/2
mice to prime MCMV-specific CD4 T cells in vitro (Figure 3D and
Text S1). To this aim, we used a monoclonal population of naive
CD4 T cells specific for an immunodominant CD4 T cell epitope
of the MCMV M25 protein [17] isolated from the spleen of a
novel TCR transgenic mouse line named M25-II (Figure S4 and
Text S1). DCs were isolated from B6 and Il102/2 mice at day
3.5 p.i., loaded with limiting amounts of M25 peptide and
incubated with CFSE-labeled M25-II CD4 T cells. Proliferation
was assessed by measuring CFSE dilution. Our results revealed
that DCs isolated from MCMV-infected Il102/2 mice supported
considerably enhanced priming capacity of TCR transgenic M25-
II cells compared to DCs from MCMV-infected B6 mice. This was
also the case for direct ex vivo antigen presenting DCs in absence of
additional peptide loading in vitro, albeit the level of proliferation
was smaller without additional peptide loading (data not shown).
Our observation that IL-10 shapes the potency of DCs to prime
virus-specific CD4 T cells already by 3.5 days p.i. suggested that
MCMV would induce early secretion of IL-10 in order to dampen
innate immune responses and to attenuate DC function,
eventually leading to impaired CD4 T cell priming. Indeed, IL-
10 levels in the serum of infected mice were detectable early upon
infection, reaching a peak at day 5 p.i. (Figure 4A). Using Il10-
GFP reporter mice, we demonstrated that MCMV induces
expression of IL-10 by various cell types, with CD4 T cells, NK
cells, DCs and macrophages being the most prominent IL-10
producers (Figure 4B). In order to dissect the in vivo relevance of
IL-10 secretion by particular cell types, we took advantage of
mixed BM chimeras in which specific cell types were unable to
produce IL-10 (Figure S5 and Text S1). Intriguingly, we identified
CD11c+ cells and to a lesser extent macrophages/neutrophils, but
not CD4 T cells, as the prominent in vivo source of IL-10 during
early MCMV infection, leading to reduced MCMV-specific CD4
T cell responses and elevated virus load during acute MCMV
infection (Figure S5).
Taken together, these data reveal that early induction of IL-10
during MCMV infection suppresses maturation of DCs, specifi-
cally targeting the myeloid CD8a2CD11b+CD11c+ subset, which
results in poor CD4 T cell priming and prolonged lytic viral
replication.
NK-like cells are crucial enhancers of CD4 T cell priming
during MCMV infection in Il102/2 mice
NK cells have recently been reported to influence the priming of
MCMV-specific CD8 T cell responses by regulating the exposure
of CD8 T cells to antigen-bearing DCs [18]. We were therefore
interested to address the impact of NK cells on the priming of
MCMV-specific CD4 T cell responses during MCMV infection in
the absence or presence of IL-10.
To evaluate the impact of NK cells on MCMV-specific CD4 T
cell priming in Il102/2 mice, we depleted NK-like cells using the
aNK1.1 antibody. Strikingly, the frequencies of MCMV-specific
CD4 T cells were massively reduced in NK-like cell depleted
Il102/2 mice to levels, which were no longer different from NK-
like cell depleted B6 mice (Figure 5A). Thus, the absence of NK-
like cells completely abolished the massive increase of MCMV-
specific CD4 T cell responses in Il102/2 as compared to B6 mice.
Consistent with a critical contribution of NK-like cells for the
priming of virus-specific CD4 T cell responses in Il102/2 mice,
depletion of NK-like cells indeed partly abolished the protective
effect of CD4 T cells observed in Il102/2 mice at day 14 post
infection (Figure 5B), since aNK1.1 depleted Il102/2mice showed
a significantly increased viral burden compared to untreated
Il102/2 mice (Figure S6A).
Furthermore, Il102/2 mice depleted of NK-like cells showed no
significant increase in the levels of IFN-c, TNF-a and IL-12 in the
sera at day 3.5 p.i. compared to B6 controls (Figure 5C). To
evaluate the impact of NK-like cells on the development of
immunopathology in Il102/2 mice, we measured body weight loss
in B6 and Il102/2 mice treated with aNK1.1 antibody and
observed that Il102/2 mice depleted of NK-like cells were
comparable to B6 controls (Figure 5D). These data indicate that
NK-like cells are key contributors to the increased levels of pro-
Figure 4. IL-10 is produced early upon MCMV infection. B6 or Il10 GFP reporter (Tiger) mice were infected with 56106 PFU Dm157 MCMV. A)
IL-10 protein concentration was determined in the sera of infected B6 mice by IL-10 ELISA Set (BD, Biosciences) at indicated time points (n = 3, data
are representative of 2 independent experiments, error bars indicate the standard deviation). B) Lung and spleen lymphocytes were isolated from
infected Il10 GFP reporter (Tiger) mice and control littermates at day 5.5 p.i. Percentages of GFP+ cells (after substraction of background fluorescence
from littermate controls) are shown for the indicated cell populations: CD4+ cells, CD8+ cells, B220+ cells (B cells), NK1.1+CD3e2 cells (NK cells),
NK1.1+CD3e+ cells (NK T cells), CD11b+CD11c2LyG/C2 cells (monocytes/macrophages) and splenic CD11c+CD11b+MHCII+B2202 cells (myeloid DCs).
(n = 3, data are representative of 2 independent experiments, error bars indicate the standard deviation).
doi:10.1371/journal.ppat.1002846.g004
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inflammatory cytokines as well as to the pathology observed in
Il102/2mice.
Flow cytometric analysis of splenic NK cell populations revealed
that Il102/2 mice exhibited decreased numbers of NK1.1+CD32
cells upon MCMV infection (data not shown, [19]). However,
although total numbers of IFN-c+ NK1.1+CD32 cells were
unaltered in Il102/2 mice (not shown), NK cells from MCMV-
infected Il102/2mice showed increased per cell expression levels of
IFN-c already at day 3.5 p.i. compared to NK cells from MCMV-
infected B6 mice (Figure 5E). Moreover, the numbers of TNF-a
producing NK cells were massively increased in Il102/2 mice
compared to B6 controls and NK cells from MCMV-infected
Il102/2mice displayed higher expression levels of the NKG2D and
NCR-1 activating receptors compared to B6 controls (Figure 5E).
Taken together, these data demonstrate that in the absence of IL-
10 NK-like cells provide critical help to virus-specific CD4 T cells,
which results in better control of lytic virus replication in Il102/2
mice. Conversely, the hyper-activated phenotype of NK cells in
Il102/2 mice results in early high levels of systemic pro-
inflammatory cytokines, which either directly or in combination
with MCMV-specific CD4 T cell-derived cytokines promote
development of pathology.
Figure 5. NK-like cells are responsible for enhanced MCMV-specific CD4 T cell response in Il102/2 mice. B6 and Il102/2 mice were
infected with 56106 PFU Dm157 MCMV. A–D) B6 and Il102/2 mice were either mock treated or depleted of NK-like cells using aNK1.1 (PK136)
antibody. A) Lymphocytes from lungs were isolated at day 5.5. p.i. and ex vivo restimulated with a pool of M14, m18, M25, M112, m139 and m142
peptides (CD4 peptide pool). Percentages of IFN-c+TNF-a+ peptide specific CD4 cells are shown (n= 3, error bars indicate standard deviation, data are
representative from at least 3 experiments). B) Virus titers were determined in salivary glands at day 14 p.i. Each symbol represents one individual
mouse, horizontal line indicates the mean, dashed line indicates detection limit (n = 3, data are representative of 2 independent experiments). C) IFN-
c, TNF-a and IL-12 protein concentrations were determined in the sera of B6 and Il102/2 mice at day 3.5 p.i. Each symbol represents one individual
mouse, horizontal line indicates the mean (n = 3, data are representative of 2 independent experiments). D) Body weight change of B6 and Il102/2
mice was measured at the indicated time points. Changes in percentage of body weight relative to day 0 are shown. Each symbol represents the
mean of 3 mice per group; vertical bars indicate the standard deviation. Data are representative of 3 independent experiments. E) Splenic
NK1.1+CD3e2 NK cells (NK) were isolated from B6 and Il102/2 mice at day 3.5 p.i. Total numbers of IFN-c+ NK cells and MFI of IFN-c+ in NK cells are
shown (upper panel). Total numbers of TNF-a+ NK cells and expression levels of NKG2D and NCR-1 on NK cells are shown (lower panel). Error bars
indicate standard deviation; n = 3, data are representative of 3 independent experiments. Statistical analysis was performed by 2-tailed unpaired
student’s t-test (* p,0.05, ** p,0.01, *** p,0.001).
doi:10.1371/journal.ppat.1002846.g005
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NK-like cells are the main contributors promoting
maturation of DCs in Il102/2 mice during MCMV
infection
Next we analyzed the mechanism by which NK cells promote
MCMV-specific CD4 T cell responses in the absence of IL-10. To
this end, we first determined the DC phenotype and priming
capacity in the absence of NK-like cells. Il102/2 and B6 mice were
depleted of NK-like cells and splenic DCs were analyzed by flow
cytometry at day 5.5 p.i. Increased numbers of splenic myeloid DCs
observed in Il102/2 mice were not seen in the absence of NK-like
cells (Figure 6A). Furthermore, expression levels of costimulatory
molecules on the surface of DCs from aNK1.1 treated Il102/2 and
B6 mice were determined by flow cytometry (Figure 6B). Interest-
ingly, when NK-like cells were depleted from Il102/2 mice, no
differences were observed any longer in the expression levels of
costimulatory molecules compared to aNK1.1 treated B6 mice.
Thus, in the absence of IL-10, NK-like cells are the main
contributors promoting maturation of DCs.
Next, the CD4 T cell priming capacity of DCs isolated from
MCMV-infected mice in the absence of NK-like cells was tested.
DCs were isolated from MCMV-infected B6 and Il102/2 mice
Figure 6. NK-like cells promote DC maturation in Il102/2 mice. B6 and Il102/2 mice were infected with 56106 PFU Dm157 MCMV and were
either mock treated or depleted of NK-like cells using aNK1.1 (PK136) antibody. A) Splenocytes from infected mice were isolated at day 5.5 post
infection. Total numbers of CD11c+MHCII+B2202 DCs and CD11c+CD11b+MHCII+B2202 DCs from infected B6 and Il102/2 mice and naive Il10 2/2
mice are shown (n= 3, error bars indicates standard deviation, data are representative of 3 experiments). B) Expression levels of MHCII and
costimulatory molecules CD80, CD86 and CD40 at day 5.5 p.i. Plots are gated on CD11c+CD11b+MHCII+B2202 DCs. Representative FACS pots (left
column) and summary of MFI data (right column, n = 3, error bars indicates standard deviation, data are representative of 3 experiments). C) Splenic
CD11c+ cells isolated at day 3.5 p.i. from NK-like depleted or undepleted B6 and Il102/2 mice were enriched by MACS, loaded with M25 peptide and
incubated with MACS purified naive CFSE-labeled TCR transgenic M25-II CD4 T for 3 days. The ratio between CFSElow M25-II cells in cultures with
Il102/2 and B6 DCs is shown (n= 3 triplicates of respective cell cultures, data are representative of 2 independent experiments). Statistical analysis
was performed by 2-tailed unpaired student’s t-test (* p,0.05, ** p,0.01, *** p,0.001).
doi:10.1371/journal.ppat.1002846.g006
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that had been treated or not with aNK1.1 antibody and incubated
with naive CFSE labeled TCR transgenic M25-II CD4 T cells.
The analysis of CFSE dilution revealed that the marked difference
in the priming capacity of naive M25-II CD4 T cells between B6
and Il102/2 mice was no longer observed when DCs from
aNK1.1 treated mice were used as APCs (Figure 6C and Text S1).
Unleashed NK/DC crosstalk drives the efficiency of CD4 T
cell priming in Il102/2 mice
Having shown that IL-10 suppresses the ability of NK-like cells
to promote DC maturation and their CD4 T cell priming
capacity, we aimed at identifying the underlying mechanism by
which IL-10 dampens NK/DC crosstalk and priming of CMV-
specific CD4 T cells. Previous reports have documented that NK
cells can interact with DCs to shape the course of the innate as well
as adaptive immune response [20]. This NK/DC crosstalk leads to
reciprocal activation, which depends on cytokines and/or mem-
brane receptor engagement. NK cell derived IFN-c and TNF-a
play important roles in promoting IL-12 production by DCs.
Conversely, DC secretion of IL-12 and IL-18 enhances cytokine
production of NK cells [21]. Moreover, NK/DC cell to cell
contact has been implied to be important in the bidirectional
cross-talk between these cell types. To identify the factors involved
in NK/DC interactions that could promote CD4 T cell priming in
the absence of IL-10, we established an in vitro co-culture system
with purified populations of NK cells, DCs and virus-specific CD4
T cells. NK cells were purified from B6 and Il102/2 mice at day
3.5 p.i. and co-cultured with M25 peptide-loaded DCs isolated
from naive mice together with naive CFSE-labeled TCR
transgenic M25-II CD4 T cells. This experimental set-up, where
only NK cells were isolated from MCMV infected mice, allowed
us to directly dissect whether NK cells impact on the capacity of
DCs to prime virus-specific CD4 T cells. Indeed, DCs co-cultured
with NK cells from MCMV infected Il102/2 mice showed an
increased priming capacity of naive virus-specific CD4 T cells
compared to DCs co-cultured with the same number of NK cells
isolated from MCMV infected B6 mice (Figure 7A). Comparably
increased proliferation of MCMV-specific CD4 T cells was
obtained when DCs were co-cultured with NK cells from MCMV
infected B6 mice in presence of an IL-10R blocking antibody (data
not shown). To identify the factors involved in these NK/DC
interactions we preformed the same in vitro co-cultures as described
above, including neutralization of IFN-c, TNF-a and blocking of
activating NK cell receptors NKG2D and NCR-1. Interestingly,
neutralization or blocking of any of those factors did not have an
influence on CD4 T cell priming when NK cells had been isolated
from infected B6 mice (Figure 7B). In contrast, when NK cells had
been isolated from Il102/2 mice, neutralization of IFN-c and
TNF-a as well as blocking of NKG2D and NCR-1 significantly
decreased the priming of virus-specific CD4 T cells (Figure 7C).
Moreover, based on our in vitro results, we tested whether some of
the factors which modulated NK/DC crosstalk in vitro would also
promote MCMV-specific CD4 T cell priming and expansion in
vivo. We therefore administered neutralizing aIFN-c, aTNF-a and
blocking aNKG2D antibodies (Figure 7 D, E). These treatments
increased the viral loads to the same extent in B6 and Il102/2
mice, compared to mock treated mice at early time points (Figure
S6B). Strikingly, the fold increase in frequencies of MCMV-
specific CD4 T cell responses was no longer different between B6
and Il102/2 mice when IFN-c or TNF-a were neutralized or
NKG2D was blocked in vivo (Figure 7D, E). Of note, in vivo
neutralization of IFN-c and TNF-a also abrogated the increased
expression levels of NKG2D and NCR-1 on NK cells normally
observed in Il102/2 mice to levels indistinguishable from NK cells
in B6 mice (data not shown), suggesting that increased levels of the
pro-inflammatory cytokines IFN-c and TNF-a in MCMV infected
Il102/2 mice presumably trigger NK cell activation more
efficiently compared to B6 controls, resulting in the upregulation
of NKG2D and NCR-1 receptors on the surface of NK cells.
Next, we hypothesized that IL-10 produced by NK cells
(Figure 4B) could be directly sensed by DCs which would result in
impaired NK/DC crosstalk and would hence account for the poor
CD4 T cell priming observed in B6 mice. In support of this
hypothesis, when DCs were isolated from naive Il10r2/2 mice and
co-cultivated with NK cells from infected B6 mice together with
naive CFSE-labeled M25 II CD4 T cells (Figure 7F), the
proliferation of M25 II cells was much more pronounced
compared to the situation where DC were isolated from naive
B6 mice (Figure 7F and B). Furthermore, also in this situation
neutralization of IFN-c and TNF-a as well as blocking of NKG2D
and NCR-1 decreased the proliferation of M25 II cells (Figure 7F).
Finally, as we had previously shown that DC-derived IL-10
suppresses MCMV-specific CD4 T cell responses in vivo (Figure
S5), we also tested in a similar co-culture setup whether IL-10
production by DCs influenced their CD4 T cell priming capacity.
To this end, NK cells from MCMV infected B6 mice were co-
incubated with naive DCs from B6 or Il102/2 mice and
proliferation of M25 II cells was assessed. Consistent with the in
vivo role of DC-derived IL-10 production, M25 II proliferation was
enhanced in co-cultures with Il102/2 DCs (Figure S7), suggesting
that DCs can produce IL-10 in response to NK cell derived factors
induced by MCMV infection, and that this autocrine suppressive
effect, in addition to IL-10 production by NK cells, may also play
an important role in balancing the outcome for the virus-specific
CD4 T cell priming in vivo.
To test whether DCs have to sense IL-10 in vivo to suppress
MCMV-specific CD4 T cell responses, we infected mice that
specifically lack IL-10Ra on CD11c+ DCs (DC-Il10r2/2, [22],
Figure 7G). Indeed, MCMV-specific CD4 T cell responses were
increased in these mice compared to controls (Il10rflox/flox).
However, CD4 T cell responses were still more pronounced in
total than in DC-specific Il10r2/2 mice. These data suggest that
DCs are one, but not the only cell type that senses and is regulated
by IL-10. It is likely that NK cells themselves are as well amongst
the earliest targets of IL-10 upon MCMV infection to curtail their
activation and cytokine production.
Taken together, these data corroborate the importance of NK
cells as promoters of DC activation and maturation and
subsequent CD4 T cell priming in MCMV infected Il102/2
mice, namely by providing soluble mediators such as IFN-c and
TNF-a, as well by cell to cell contact with involvement of the
NKG2D and NCR-1 receptor. In contrast, the intensity of NK/
DC synergy is markedly diminished in the presence of IL-10
leading to poor CD4 T cell priming with both DC and NK cells
presumably being the early and important targets as well as
sources of IL-10.
Conversely, it is known that DCs in turn can also promote
activation of NK cells. IL-12 is one of the DC-derived cytokines
that stimulates NK cell cytokine production. Moreover, IL-10
influences the IL-12/IFN-c positive feedback loop during NK/DC
crosstalk [23], but the consequences of these regulatory effects on
the adaptive immune response during viral infections remain
largely unknown. Since Il102/2 mice produced more IL-12 in
response to MCMV and NK1.1. depleted Il102/2 mice showed
decreased levels of IL-12 (Figure 5C), we sought to define the
impact of IL-12 on the induction of NK cell and virus-specific
CD4 T cell responses in the absence of IL-10 (Figure 8). aIL-12/
p40 antibody-mediated neutralization of IL-12 reduced NK cell
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secretion of IFN-c in B6 as well in Il102/2 mice, and secretion of
NK cell derived TNF-a was markedly reduced in Il102/2 mice to
the levels of B6 controls on day 5.5 p.i. (Figure 8A). Consistent
with the role of NK cells in promoting MCMV-specific CD4 T cell
priming in absence of IL-10, CD4 T cell responses were no longer
increased in Il102/2 mice compared to B6 mice when IL-12 was
neutralized in vivo (Figure 8B). Albeit neutralization of IL-12 led to
increased viral loads at day 5.5 p.i., this increase in viral load was
comparable in B6 and Il102/2 mice (Figure S6C). These data
show that IL-12 plays a potent role in the activation of NK cells in
Il102/2 mice by promoting NK cell cytokine production and IL-
12 thereby contributes indirectly to increased virus-specific CD4 T
cell responses in Il102/2 mice.
Collectively, these data establish that IL-10 critically dampens
the strength of the NK/DC crosstalk and thereby suppresses
MCMV-specific CD4 T cell responses (Figure S11). Absence of
IL-10 during MCMV infection unleashes a potent positive
feedback loop between NK cells and DCs: NK cells produce
more IFN-c and TNF-a in MCMV-infected Il102/2 mice and, in
combination with NKG2D and NCR-1 receptor engagement,
promote DC activation which in turn facilitates priming of
MCMV-specific CD4 T cells. Furthermore, DCs from MCMV-
infected Il102/2 mice produce more IL-12, leading to exacerbated
activation of NK cells and consequently virus-specific CD4 T cells.
Unleashed NK/DC crosstalk in MCMV-infected Il102/2 mice
therefore enables enhanced control of lytic viral replication via
more potent activation of MCMV-specific CD4 T cell immunity,
albeit at the expense of increased host pathology.
Discussion
In order to regulate T cell mediated immunity during infections,
in particular during chronic types of infection, IL-10 exerts
pleiotropic direct and indirect suppressive effects towards different
cell types of the innate and adaptive immune response [24]. The
presence of an IL-10-mediated anti-inflammatory condition
during early phases of an immune response can negatively affect
the size and quality of the ensuing adaptive immune response.
Such suppression of adaptive immunity may be pivotal in
preventing harmful immune-mediated tissue damage for the host,
Figure 7. Unleashed NK/DC crosstalk promotes CD4 T cell priming in Il102/2 mice. B6 and Il102/2 mice were infected with 56106 PFU
Dm157 MCMV. A–C,F) DX5+CD32 (NK) cells were isolated from B6 and Il102/2 mice by MACS at day 3.5 p.i. Splenic DCs were isolated from naive B6
(A–C) mice or naive Il10r2/2 mice (F) by enrichment for CD11c+ cells. MCMV-specific CD4 T cells were isolated by MACS from spleens of naive M25-II
mice and labeled with CFSE. CD11c+ cells were loaded with M25 peptide and co-cultured with CFSE-labeled M25-II cells without (no NK) or with
addition of DX5+CD32 (NK) cells isolated from B6 (A, B, F) or Il102/2 (A, C) mice. As indicated, blocking antibodies for IFN-c, TNF-a, NKG2D and NCR-1
were added to cultures. The frequencies of CFSElow M25 II cells are shown. (n = 3, data are representative of 3 independent experiments). Dotted lines
indicate the mean level of M25-II CFSE dilution in cultures without NK cells (no NK). D, E) B6 and Il102/2 mice were treated in vivo with aIFN-c
antibodies at days 3 and 4 p.i. (D); with aTNF-a and aNKG2D antibodies at days 0, 3, 4 p.i. (E). Lymphocytes from lungs of infected mice were isolated
at day 5.5 p.i. and ex vivo restimulated with a pool of M14, m18, M25, M112, m139 and m142 peptides (CD4 peptide pool). Fold increase (D, E) of IFN-
c+ TNF-a+ peptide specific CD4 cells between Il102/2 and B6 mice is shown (n = 3, error bars indicates standard deviation, data are representative for
3 experiments). G) DC- Il10rflox/flox, Il10rflox/flox and Il10r2/2 mice were infected with 56106 PFU Dm157 MCMV. Lymphocytes from lungs were
restimulated with the CD4 peptide pool. Total numbers of IFN-c+ TNF-a+ peptide-specific CD4 cells are shown. (n = 3, data are pooled from 2
independent experiments). Statistical analysis was performed by 2-tailed unpaired student’s t-test (* p,0.05, ** p,0.01, *** p,0.001).
doi:10.1371/journal.ppat.1002846.g007
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but as a consequence is often associated with increased pathogen
burden. For these reasons, viruses that cause chronic infections
often exploit the IL-10 pathway in order to modulate the virus-
host balance towards their own benefit. Here we establish that IL-
10 markedly impairs priming of MCMV-specific CD4, but not
CD8 T cell responses, by selectively attenuating maturation of
CD8a2CD11b+CD11c+ myeloid DCs, which are crucial for the
activation of MCMV-specific CD4 T cells. In contrast, IL-10 does
not affect CD8a+ lymphoid organ-resident DCs, which are pivotal
for the priming of MCMV-specific CD8 T cells [16]. This
impaired MCMV-specific CD4 T cell priming in the presence of
IL-10 results in prolonged MCMV replication together with
limited TNF-a mediated immunopathology. Furthermore, we find
that NK cells are a critical component promoting the maturation
of myeloid DCs during MCMV infection of Il102/2 mice, since
depletion of NK cells in Il102/2 reduces MCMV-specific CD4 T
cell priming to levels observed in B6 mice. In the absence of IL-10,
NK cells produce more IFN-c and TNF-a, promoting, in
combination with NKG2D and NCR-1 receptor engagement,
the functional potency of MCMV-specific CD4 T cell priming by
myeloid DCs. Moreover, in the absence of IL-10, DCs secrete
more IL-12, which enhances activation and cytokine release of
NK cells. Thus, the increased intensity of the NK/DC crosstalk
plays a critical role for the massive priming of MCMV-specific
CD4 T cell responses in the absence of IL-10. The downstream
effect of an increased MCMV-specific CD4 T cell response in
absence of IL-10 is accelerated control of lytic MCMV replication,
which is, however, associated with more severe immunopathology.
Opposed to our results, immune-stimulatory effects of IL-10 on
NK cells have also been reported, but mainly coming from in vitro
studies [25–27]. In contrast to these in vitro data, a number of
published in vivo studies [28,29] also support a suppressive rather
than activating effect of IL-10 on NK cells during an inflammatory
response.
In our study, we used an MCMV mutant which lacks the m157
gene, thereby abolishing the direct activation of NK cells via
Ly49H. We aimed to assess whether strong NK cell activation
through Ly49H would lead to dominance of NK cell cytotoxic
activity towards DCs in the absence of IL-10, thus resulting in an
impaired rather than an increased virus-specific CD4 T cell
response in Il102/2mice. However, this was not the case, since we
corroborated our main findings by infecting mice with wt MCMV:
Il102/2 mice harbored reduced virus loads 2 weeks post infection
and virus-specific CD4 T cell priming was significantly increased
in Il102/2 mice compared to B6 mice already at day 5.5 post
infection (Figure S8). Furthermore, CD8a2CD11b+ myeloid DCs
were markedly influenced in their activation phenotype in Il102/2
mice compared to B6 mice with higher expression levels of
costimulatory markers (Figure S9B, C). Moreover, NK-like cells
played a crucial role in promoting maturation of myeloid
CD8a2CD11b+ DCs and CD4 T cell priming in the absence of
IL-10, since depletion of NK-like cells abolished the enhanced
activation phenotype of CD8a2CD11b+ DCs and CD4 T cell
response in Il102/2 mice to the level of B6 control mice depleted
of NK-like cells (Figure S9A). Furthermore, when we used a lower
dose of viral inoculum, IL-10 suppression of NK/DC crosstalk and
CMV-specific CD4 T cell priming was observed, indicating that
the described effects are prominent even when the overall extent of
inflammation is reduced (Figure S10).
Attenuation of DC maturation and function is a strategy
actively exploited by herpes viruses to compromise the adaptive
immune response of the host and thereby to prolong replication
and consequently the chance for horizontal transmission. HCMV
encodes an IL-10 homolog (cmv-IL10), which exerts suppressive
effects on DC maturation, migration and cytokine secretion [5].
Here we document the importance of IL-10 in regulating the
magnitude of this NK/DC crosstalk during MCMV infection with
direct impact for the induction of adaptive antiviral immunity.
NK/DC cell to cell contact has been implied to be important in
the cross-talk between these cell types. DCs are important targets
of MCMV infection and the NKG2D receptor is considered to be
involved in mutual interactions of NK cells and MCMV-infected
DCs. However, the exact mechanism of this interaction still
remains unknown. We observed that NK cells from Il102/2 mice
show increased levels of the NKG2D and NCR-1 activating
receptors as well as increased production of TNF-a and IFN-c per
cell level compared to B6 controls and we showed that all of those
critically promote NK/DC crosstalk resulting in augmented virus-
specific CD4 T cell priming. We have not considered a role of
other NK cell receptors in this study, but it is conceivable that an
overall threshold of signals coming from activatory and inhibitory
NK cell receptors is shifted in the absence of IL-10.
Recently, in the context of HIV infection, it has been shown
that IL-10 induction leads to changes in DC compartments and
suppresses NK killing of immature DCs, thus promoting
accumulation of poorly immunogenic APCs, which contribute to
the immune dysfunction observed in HIV patients [30]. In the
context of HCV infection, expression of the NKG2A inhibitory
receptor on NK cells was shown to trigger production of the
immunosuppressive cytokines IL-10 and TGF-b by NK cells,
Figure 8. IL-12 contributes to enhanced CD4 T cell priming in
Il102/2 mice. B6 and Il102/2 mice were infected with 56106 PFU
Dm157 MCMV and treated in vivo with aIL-12 antibody at days 0, 3,
4 p.i. A) Splenic NK1.1+CD3e2 NK cells (NK) were isolated from B6 and
Il102/2 mice at day 3.5 p.i. Total numbers of IFN-c+ NK and TNF-a+ cells
are shown (error bars indicate standard deviation; n = 3, data are
representative of 2 independent experiments). B) Lymphocytes were
isolated from lungs at day 5.5 p.i. and ex vivo restimulated with the CD4
peptide pool. Fold increase in IFN-c+ TNF-a+c peptide specific CD4 T
cells between Il102/2 and B6 is shown (n= 3, error bars indicates
standard deviation, data are representative from 3 independent
experiments). Statistical analysis was performed by 2-tailed unpaired
student’s t-test (** p,0.01, *** p,0.001, n.d. = not detected).
doi:10.1371/journal.ppat.1002846.g008
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which suppressed the ability of DCs to prime Th1 polarized CD4
T cells [31].
The impact of NK cells on the regulation of virus-specific T cell
responses during persistent infections has been evaluated in several
studies. On one hand, NK cells promote MCMV-specific CD8 T
cell responses by regulating the production of type I IFN by
plasmacytoid DCs [32]. Moreover, strong activation of NK cells
achieved by the use of recombinant Rae1c MCMV virus induces
protective CD8 T cell immunity and antibody responses [33]. In
contrast, NK cells can also reduce the magnitude of T cell
responses by directly lysing antigen-bearing immature DCs and
thus curtailing T cell priming [21]. Ly49H-expressing NK cells
lyse infected conventional DCs upon MCMV infection, thereby
limiting virus-specific CD8 T cell priming [18]. IL-10 production
by Ly49H expressing NK cells during uncontrolled MCMV
infection of Prf12/2 mice has been suggested to play an important
role in limiting CD8 T cell responses and immunopathology [34].
Moreover, very recent reports have shown that NK cells can have
a direct cytotoxic effect towards activated CD4 and CD8 T cells
during chronic LCMV Clone 13 infection with an impact on
virus-induced immunopathology [35,36]. Thus, there seems to be
a controversy with two opposing effects of NK cells in either
promoting or suppressing virus-specific T cell responses during
viral infection. It has been proposed that the ratio of NK cells and
DCs could direct the role of NK cells either towards promotion or
restriction of virus-specific T cell responses in vivo [18,37].
Specifically, the presence of high numbers of NK cells vs. DCs
during an infection would lead to predominance of NK cell
cytotoxicity towards immature DCs, suppressing the priming of
virus-specific T cells. In contrast, low numbers of NK cells vs. DCs
would lead to NK/DC interactions that stimulate priming of the
virus-specific T cell response. Taking into account that IL-10
reduces activation-induced NK cell death and accumulation of
cytotoxic NK cells during the acute phase of MCMV infection
[19], one could argue that early induction of IL-10 during MCMV
infection may lead to high NK/DC ratios, a scenario in which NK
cells suppress T cell priming by lysing DCs. Our data are in line
with such a hypothesis, since we demonstrate that immunogenic
NK/DC crosstalk is attenuated and overridden by IL-10 with
direct consequences for the induction of protective CD4 T cell
immunity.
Upon infection, IL-10 can be secreted by many different cell
types [3]. T and B cells, DCs, macrophages and NK cells produce
IL-10 during various chronic viral infections [24]. During MCMV
infection, IL-10 secretion by CD4 T cells and B cells, inflamma-
tory macrophages and DCs has been reported [7,19,38]. Here we
confirmed that MCMV infection induces IL-10 production,
assessed by IL-10 reporter activity, by various cell types, including
myeloid DCs, macrophages, NK cells, CD4 T cells and B cells.
Thus, the relative contribution of each IL-10 producing cell type
to the overall in vivo effects of this immunosuppressive cytokine is
likely very complex and it might also differ depending on the tissue
and the time of infection. We identified CD11c+ cells and to some
extent macrophages, but not CD4 T cells, to be important in vivo
sources of IL-10 during acute MCMV infection using mixed bone
marrow chimeras in which specific cell types were IL-10 deficient.
Although CD4 T cells showed prominent IL-10 reporter activity
during MCMV infection, CD4 T cell derived IL-10 was
dispensable for constraining MCMV-specific CD4 T cell responses
and virus control. This discrepancy either indicates that IL-10
reporter activity does not accurately reflect IL-10 protein
production in vivo, perhaps due to posttranscriptional regulation
as shown for NK cells [39], or that CD4 T cell-derived IL-10 does
not contribute to suppress MCMV-specific CD4 T cell responses
because of potential anatomical or kinetic constraints of the IL-10
source which are not met by CD4 T cells. Also, it will be of interest
to assess the in vivo role of NK cells as an early source of IL-10
during MCMV infection in future studies.
A recent report addressed the impact of IL-10 on MCMV-
specific CD8 T cell responses during the latent phase of MCMV
infection [13]; although IL-10 did not alter early priming of
MCMV-specific CD8 T cells, it limited CD8 T cell memory
inflation. It is conceivable that the increased memory CD8 T cell
inflation in the absence of IL-10 is a direct consequence of the
greatly increased MCMV-specific CD4 T cell response, as CD4 T
cells support memory CD8 T cell inflation [40]. In line with this
hypothesis, CD8 T cells specific for the IE-3 epitope, previously
shown to be highly dependent on CD4 T cell help [40,41], were
profoundly increased in Il102/2 mice.
In conclusion, we identified an important role of IL-10 during
early MCMV infection and its impact for priming of MCMV-
specific CD4 T cell responses. By suppressing the innate-adaptive
immune cell crosstalk and, in particular, regulating the strength of
NK/DC interactions, IL-10 specifically limits the activation of
virus-specific CD4 T cells, which in turn leads to reduction of host
tissue damage but promotes virus persistence in the long run (Fig.
S11). These two opposing effects of IL-10 in regulating the virus-
host balance during primary CMV infection should be taken into
account when considering therapeutic properties of this immuno-
suppressive cytokine.
Materials and Methods
Ethics statement
This study was conducted in accordance to the guidelines of the
animal experimentation law (SR 455.163; TVV) of the Swiss
Federal Government. The protocol was approved by Cantonal
Veterinary Office of the canton Zurich, Switzerland (Permit
number 145/2008, 109/2011).
Mice, viruses, peptides and in vivo antibody treatment
C57BL/6J, Il102/2, Il10rb2/2 mice were bred in the local
animal facility under specific pathogen free conditions. Il10 GFP
knock-in Tiger mice were generated and provided by Dr. R. A.
Flavell (Yale University, USA). DC-Il10r2/2 [22] and CD11c-
DTR/GFP mice [42] were previously described and LysMCre/
iDTR mice were kindly provided by Dr. T. Buch (Technical
University, Munich, Germany). BAC-derived MCMV MW97.01
(WT MCMV in the text) and recombinant MCMV Dm157 were
previously described [17] and were propagated on C57BL/6
embryonic fibroblasts (MEFs). Viral titers were determined by
standard virus plaque assay [43]. Mice were infected intravenously
(i.v.) with 56106 plaque forming units (PFU) of MCMV. The
MCMV derived m14aa136–150, M25aa411–425, M25aa721–735,
M112aa36–50, m142aa26–40 m139560–574, M45aa985–993, M38aa316–323
peptides were purchased from NeoMPS (Strasbourg, France).
CD8 and CD4 T cells were depleted in vivo with 0.2 mg of
purified anti-mouse CD8 and anti-mouse CD4 monoclonal
antibodies (YTS 169.4 respectively YTS 191.1). Mice were
injected i.p. 3 and 1 days before infection and then weekly. NK-
like cells were depleted with 0.5 mg of anti-NK.1.1 monoclonal
antibody (PK136, BioXCell). Mice were injected i.p. at the day 1
before infection and every second day post infection. TNF-a,
IFN-c and IL-12 were neutralized with 0.5 mg of anti-TNF-a
(XT3.11, BioXCell), anti-IFN-c (XMG1.2, BioXCell) and anti-
IL-12 (C17.8, BioXCell) antibodies and NKG2D was neutralized
with 0.5 mg of anti-NKG2D (HMG2D, BioXCell) antibody.
Mice were injected i.p. at day of infection and on days 3 and 4
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post infection except for anti-IFN-c where mice were injected at
day 3 and 4 post infection.
Antibodies and tetramers
APC-conjugated peptide-MHC class I tetramers were generated
as described (Altman JD, 1996). The following fluorochrome-
conjugated antibodies were obtained either from Biolegend
(Lucerna-Chem AG, Luzern, Switzerland) or from BD Biosciences
(Allschwil, Switzerland): anti-CD4, anti-CD8, anti-NK1.1, anti-
CD3e, anti-TCRVa11.1, anti-CD11c, anti-CD11b, anti-B220,
anti-I-Ab, anti-Ly6C, anti-TNF-a, anti-IFN-c, anti-CD45.1, anti-
CD40, anti-CD86, anti-CD80 and anti-NKG2D.
Stimulation of lymphocytes, cell surface and intracellular
stainings and flow cytometry
Lymphocytes were isolated from spleen, lung, liver, lymph
nodes and salivary gland as previously described [17,44]. For
intracellular cytokine stainings, CD4 T cells were first stimulated
with 3 mg/ml of CD4 peptide pool (m14aa136–150, M25aa411–425,
M25aa721–735, M112aa36–50, m142aa26–40 m139560–574) and CD8 T
cells were restimulated with 1 mg/ml of M45aa985–993, M38aa316–
323 peptides in the presence of 10 mg/ml brefeldin A (Sigma
Aldrich) at 37uC for 6 hours. Cells were stained for cell surface
markers with directly conjugated antibodies and incubated for
20 min at 4uC or at 37uC when using tetramers. For intracellular
cytokine stainings cells were then fixed and permeabilized using
Fix/Perm solution (FACSLyse diluted to 2X concentration and
0.05% Tween 20) for 10 min at room temperature. Cells were
then washed and stained with directly labeled anti-IFN-c and anti-
TNF-a antibodies for 20 min at 4C. Multiparameter FACS
analysis was performed on a LSRII flow cytometer (BD
Bioscience) using FACS DIVA software (BD Bioscience). Data
were analysed using FlowJo software (Treestar).
CD4 T cell proliferation assay
M25-II cells were isolated by MACS from splenocytes of naive
M25-II transgenic mice by positive selection with anti-CD4
microbeads (Miltenyi Biotech). Cells were labeled with 0.5 mM
CFSE (Invitrogen) for 8 min at 37uC. CD11c+ cells were isolated
by MACS from spleens of B6 and Il102/2 mice by positive
selection with anti-CD11c microbeads (Miltenyi). 16105 CD11c+
cells of infected B6 and Il102/2 mice were loaded with 1028 M of
M25 peptide and co-cultured with 66104 CFSE labeled M25-II
cells. After 3 days of incubation, cells were stained with anti-CD4
and anti-CD45.1 antibodies and CFSE dilution was measured by
flow cytometry.
NK/DC/CD4 T cell proliferation assay
M25-II cells were isolated and CFSE labeled as described
above. Naive CD11c+ cells were isolated from the spleens of B6
and Il10r2/2mice as described above. NK cells were isolated from
the spleens of infected B6 and Il102/2 mice at day 3.5 post
infection as previously described [45]. Briefly, splenocytes were
first negatively depleted of T cells using FITC-conjugated anti-
CD3e and anti-FITC microbeads (Miltenyi). NK cells were then
positively selected by staining the T cell-depleted fraction with
anti-DX5 beads (Miltenyi). 26105 of purified NK cells were co-
cultured with 66104 CFSE labeled M25-II cells and 16104
CD11c+ cells in 96-U bottom plates and treated with or without
50 mg/ml anti-IFN-c, 50 mg/ml anti-TNF-a or 3 mg/ml anti-
NKG2D antibodies (all purchased from BioXcell) and 5 mg/ml of
purified NCR-1 monoclonal antibody (provided by Prof. S. Jonjic).
After 3 days of incubation, cells were stained with anti-CD4 and
anti-CD45.1 antibodies and CFSE dilution was measured by flow
cytometry.
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